טוען...
Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma
Uterine serous adenocarcinoma is a rare but highly malignant form of endometrial cancer, comprising over 50% of recurrences and deaths from endometrial cancer. We report a case of a 68-year old woman with recurrent uterine serous adenocarcinoma who underwent molecular testing and genetic sequencing...
שמור ב:
| הוצא לאור ב: | Gynecol Oncol Rep |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6411491/ https://ncbi.nlm.nih.gov/pubmed/30906838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2019.01.013 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|